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Abstract 
Aim: To evaluate the safety and efficacy of a 980nm diode laser for the treatment of benign 
facial pigmented and vascular lesions, and in oral surgery. 
Materials and Methods: 20 patients were treated with a 980 nm diode laser. 
Oral surgery: 5 patients (5 upper and lower frenulectomy). Fluence levels were 5-15 J/cm
2; 
pulse lengths were 20-60 ms; spot size was 1 mm. 
Vascular lesions: 10 patients (5 small angiomas, 5 telangiectases). Fluences were 6-10 J/cm
2; 
pulse lengths were 10-50 ms; spot size was 2 mm. In all cases the areas surrounding the le-
sions were cooled. 
Pigmented lesions: 5 patients (5 keratoses). All the lesions were evaluated by dermatoscopy 
before the treatment. Fluence levels were 7-15 J/cm
2; pulse lengths were 20-50 ms; spot size 
was 1 mm.   
All the patients were followed at 1, 4 and 8 weeks after the procedure.   
Results: Healing in oral surgery was within 10 days. The melanoses healed completely 
within four weeks. All the vascular lesions healed after 15 days without any residual scarring. 
Conclusions: The end results for the use of the 980 nm diode laser in oral and facial sur-
gery appears to be justified on the grounds of efficacy and safety of the device, and good 
degree of acceptance by the patients, without compromising their health and function. 
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1. Introduction 
Benign facial lesions both pigmented (keratoses, 
melanoses) and vascular (angiomas, linear telangiec-
tases) are very frequent, and affect many adults of 
either sex with fair complexions [1,2]. 
Keratoses are circumscribed scaly lesions, lo-
cated in the epidermis and composed of a prolifera-
tion of pigmented keratinocytes. Yellow-brown in 
colour, they range from dark yellow to black and can 
be divided into: 
•  seborrheic keratoses, with internal horny pseu-
docysts 
•  actinic or senile keratoses that develop in areas 
exposed to the sun. 
Melanosis or hyperchromias are circumscribed 
pigmented lesions, with extracellular melanin pig-




range in colour from black in superficial melanoses to 
brown in deep melanoses. 
Angiomas are small elevated lesions, telangiec-
tases (0.1-1mm diameter) are capillary dilatations of 
the subpapillary plexus. Red or pink in colour, they 
have thin walls with endothelial cells and slight basal 
membrane. Angiomas may show parietal endothelial 
proliferation. For some pigmented lesions (seborrheic) 
etiology is unknown, while the other pigmented le-
sions and the vascular lesions are brought about by 
solar and artificial irradiation as well as genetic pre-
disposition. 
In the past, besides chemical sclerosis for large 
vascular angiectasias, these lesions were treated by a 
variety of methods including electrocoagulation, 
cryotherapy, acid chemical agents (Trichloroacetic 
acid) and depigmenting agents (Hydrochinone), and 
C02, Ruby, Argon Laser systems either focussed or 
combined with dermoabrasive scanners [1-3]. 
The results were often evident scarring or 
dyschromia due to the lack of selectivity of the device; 
Ruby and Argon lasers, despite having an excellent 
chromophoric specificity for melanin-hemoglobin, 
did not allow photothermolysis owing to inappropri-
ate pulsing for the treatment of smaller structures that 
don’t require pulse durations of hundreds of milli-
seconds [4]. With Argon lasers, moreover, recurrences 
were frequent [3]. 
In medical practice a current treatment is now 
considered to be photocoagulation by Laser or Lamps 
with intense incoherent light, at selective wavelengths 
for melanin-hemoglobin chromophores, and emitting 
optimal pulses and fluences, in accordance with the 
principle of selective photothermolysis [3,5].   
To this end, different monochromatic coherent 
sources may be used:  
•  in the visible region with: 1) green light 510, 532 
nm, (Copper Br., KTP, Kripton); 2) yellow light 
577, 585, 600 nm, (Dye, Vapour-Copper Br.); 3) 
red light 694 nm (Ruby) 
•  in the invisible region: - I.R. close to 755, 980, 
1,064 nm (Alexandrite, Diode, Nd.-YAG). [Table 
1] 
 
The microcrusts resulting from vascular photo-
sclerosis only last a few days and are to be considered 
a normal consequence of the treatment [6]. 
Only ultrashort pulses (450 ns) in a 577-600 nm 
Dye Lasers cause an unsightly purpora to develop on 
the vessels lasting 7-15 days as a result of the capil-
laries bursting under the excessively short shock 
waves [7]. This inconvenience delays the patients' 
return to their routine activities. 
For the principle of selective photothermolysis to 
be respected Physics imposes a set of "ideal" theo-
retical parameters,which are: 
•  wavelength for selective absorption by chro-
mophores:  melanin (335-532 nm)[8], hemoglo-
binin(500-580nm;) [9,10], oxy-hemoglobin (580 nm;) 
[9,10], deoxy-hemoglobin(760nm;)[9,10] 
•  adequate fluence or energy dose; 
•  pulse duration proportionate to the target di-
ameter to respect the thermal relaxation time. 
When applying the technique in clinical practice 
operators should consider: 
•  the many individual cutaneous variables (pho-
totype, scarring, site, chromia, size, thickness, 
depth of the lesion); 
•  the ability to control the equipment with critical 
assessment of the different Lasers and 
high-intensity Lamps in terms of size, weight, 
"fragility", learning curve and high equipment 
purchase and running costs. 
The clinical evidence of lesions with inhomoge-
neous melanin distribution (yellow, brown and black 
tones) and oxydeoxyhemoglobin distribution (red, 
purple, blue) prompted us to question the efficacy of 
the 980nm Laser for photosclerosis of lesions and ar-
eas with little melanin and hemoglobin pigmentation 
[7]. 
Furthermore, to avoid exaggerated fluences and 
thermal damage to the surrounding tissues, and in 
accordance to J.A. Parrish's view [6] that exogenous 
chromophores are able to "target, manipulate, confine 
and control" the effects of Laser light in living system, 
in several cases is possible to use a readily available 
artificial photothermoabsorbant chromophore - 1% 
methylene blue - less expensive than the optimal in-
docyanine green, to mark the hypochromic keratoses 
and angiomas in order to artificially increase their 
ability to absorb the Laser light.  
Innovative technologies such as the diode laser 
have provided considerable benefit to dental patients 
and professionals. Due to the conservative nature of 
treatment accomplished with the laser this technology 
is very useful in surgical dental procedures. The diode 
laser is utilized in both aesthetic enhancement of the 
smile, and treatment management of soft tissue issues 
[11]. 
Additionally Dental lasers contribute signifi-
cantly to the field of cosmetic dentistry, providing an 
invaluable resource for clinicians who perform dif-
ferent types of aesthetic procedures. Practitioners in 
this specialized field not only help patients acquire 
beautiful and ideal smiles and dental health, but also 
they assist patients in benefiting from tremendous 
clinical advantages, such as bacterial reduction in 









Following the suggestions of scientific literature 
on the advantages of the compactness, reliability, ease 
of use and affordability of the 980 nm Diode Lasers, 
we evaluated the efficacy and safety of one such Laser 
for the treatment of pathological frenulum, keratoses, 
angiomas and telangiectases. 
2. PATIENTS AND METHODS 
The treatment with the 980nm Diode Laser was 
proposed to a group of 15 patients phototypes 1-4, 
according to Fitzpatrick [19,20], with benign facial 
pigmented or vascular lesions, and to a group of 5 
patients with pathological frenulum. 
Exclusion criteria were a history of malignant 
pigment tumour, anticoagulation therapy or altera-
tions in the clotting system and cutaneous wound 
healing with a tendency to form keloids. 
Informed consent was obtained from all patients, 
in accordance with the declaration of Helsinki. 
The diagnostic work-up included a clinical ex-
amination followed by videomicroscopy, to validate 
the preoperative diagnosis. 
The lesions were also photographed before, im-
mediately after and two months after treatment. 
Pigmented lesions. This group comprised 5 pa-
tients (4 women and 1 men; age range 46-75 years); 
with senile keratosis (solar lentigo) [Fig.1a] varying in 
size from 2x2mm to 10xl5mm.   
The area comprising the lesion was cooled by 
applying ice for 2 minutes immediately before and 
after the laser session. 
The procedure was performed with fluences 
from 7 to 15 J/cm2, a pulse length of 20-50 ms, a spot 
diameter of 2 mm. In three "sensitive" patients we 
used a topical anaesthetic (EMLA® AstraZeneca LP, 
Wilmington, Del). A small anallergic plaster was ap-
plied for three days to the residual areas of the larger 
pigmentations. 
Vascular lesions. This group consisted of 10 pa-
tients (7 women and 3 men; age range 23-68 years). 
We treated 5 red linear telangiectases with diameters 
above 0.5mm [Fig.2a] and 5 angiomas ranging in size 
between 2x2 and 3x4 [Fig.3a]. All telangiectases were 
anaesthetised with cream (EMLA® AstraZeneca LP, 
Wilmington, Del) and then cooled by applying ice for 
2 minutes before and after photosclerosis. 
The Laser settings were: fluence between 6 and 
10 J/cm2, variable pulse length between 10 and 50 ms, 
and a spot diameter of 2 mm.   
After the procedure the lesions were medicated 
for 5 days with a water-based cream containing 0.1% 
gentamicin and 0.1% betamethasone..  
Oral surgery. This group comprised 5 patients. 
The Laser settings were: fluence between 5 and 15 
J/cm2, variable pulse length between 20 and 60 ms, 
and a spot diameter less than 1mm in frenulectomy. 
Oral tissues were treated without local intra-tissue 
anaesthesia [17]. 
The patients described the procedure as totally 
painless [Fig.4a]. All patients returned to their routine 
activities without delay.  
No haemorrhage was observed either during 
treatment or during the healing period. 
All the patients were followed up at 1, 4, and 8 
weeks from the procedure. 
3. RESULTS 
At the 4-week follow-up the cases of keratosis, 
had completely healed without scarring [Fig.1b]. 
There were no infections. All patients were satisfied 
with the treatment and the results obtained. 




had healed without leaving any macroscopically visi-
ble scars [Fig.2b,3b], after the appearance for half a 
day of erythema with moderate serum secretion and 
microcrasts for 5-7 days. 
In all oral surgical procedures, no haemorrhage 
was observed either during treatment or during the 
healing period. No sutures were required. The pa-
tients were comfortable with no pain, either in-
tra-operatively or post-operatively. Haemostasis was 
optimum immediately after the procedure [Fig.4b]. 
Ten days later the procedure, each healing was found 






Figure 1. a: Solar lentigo cheek pretreatment. b: Solar 




Figure 2. a: nasal telangiectases before treatment. b: nasal 




Figure 3. a: angioma pretreatment. b: angioma 4 weeks 









Figure 4. a: upper lip frenulum pretreatment. b: upper lip 
frenulum immediatedly post treatment. c: upper lip frenu-
lum 10 days after treatment 
 
4. DISCUSSION AND CONCLUSIONS 
Laser technology is developing very quickly. It is 
an instrument that achieves maximum oral health in a 
minimally invasive fashion. New Lasers with a wide 
range of characteristics are available today and are 
being used in the various fields of medicine and den-
tistry [4,7,9,12,20,21]. The search for new devices and 
technologies for dental procedures was always chal-
lenging and in the last two decades much experience 
and knowledge has been gained. Applications now 
are being developed for a broader range of wave-
lengths that will offer useful, predictable, and com-
fortable therapy for managing of dental patients. Par-
ticularly, the use of a diode laser seems to be promis-
ing, in patients, who need to be treated with a tech-
nique where the operative and post-operative blood 
loss and post-operative discomfort are reduced 
[17,18].  
The lasers normally adopted offer the enormous 
advantage of being conveyed in a fibre, which serves 
as the working tip at the end of the handpiece. The 
use of flexible, length-adjustable optical fibre also 
enables efficacious irradiation i.e. the less accessible, 
deeper pockets in periodontal disease [13,15]. 
The most frequently used optical fibre has a 
diameter of 300 µm.  
The targeted and controlled treatment of benign 
pigmented and vascular lesions using selective lasers 
(with wavelengths of 600-980 nm) and high-intensity 
lamps (Xenon) is now generally accepted. These are 
the most suitable tools for photocoagulating these 
small superficial lesions, allowing excellent results to 
be obtained painlessly, in a short time and without 
requiring the patients to suspend their routines ac-
tivities.  
For the operators, the main barriers to acquiring 
these tools are their high cost in terms of purchase, 
installation, management and, for some devices, even 
running and maintenance costs; space, weight and 
cooling devices that requires electrical systems to be 
upgraded are other factors that hinder the spread of 
these tools. In our practices we often encounter scars 
caused by naive operators who have been persuaded 
by unprofessional salespeople that "these intelligent 
machines" can replace "the brain and hand, skill and 
experience" of the specialist.  
The aim of this study was to verify the reliability 
and efficacy of one of these compact portable diode 
instruments, emitting a maximum power density of 
30W/cm2 not requiring pre-warming or controlling, 
and delivering a wavelength of 980 nm. 
This device is naturally less selective and there-
fore less effective on melano-hemoglobin chromo-
phores than those at less than 510-532-577 nm, which 
are however delivered by machines that: 
•  weigh up to over 100 Kg, 
•  are delicate as they can only be activated in 
air-conditioned environments with controlled 




•  expensive in terms of maintenance and running 
costs. 
Also Q-switched. Nd:YAG and ruby sources 
appear to be interesting [23-25]. 
Angiectases of the lower limbs, where the skin is 
thick, are deeper and are most often blue, and rarely 
purple-red. These lesions should all be treated after an 
accurate diagnosis and only after the major deep re-
fluxes have been eliminated by surgery and sclero-
therapy [26]. 
Purple-red angiectasias with a size of 1-3mm are 
arterial and/or arteriovenous and/or anteriovenous 
fistula dilatations; they are sometimes confused with 
neoangiogenesis or "matting", deriving from an "un-
fortunate" chemical sclerosis. 
A l t h o u g h  t h e y  h a v e  b e e n  d e s c r i b e d  a s  v e n o u s  
capillary dilatations for their endothelial characteris-
tics, they present greater oxygen saturation 76%, (69% 
for the blue ones) and have such a fast-flowing inter-
nal circulation that the scierotherapic substances are 
prevented from having sufficient contact to determine 
the reactive endothelitis and fibrosis. 
In these cases lasers are indicated as a supple-
ment to chemical sclerosis [26,27]. 
On the basis of the results obtained in the treat-
ment of benign facial pigmented and vascular lesions, 
while recognising the physical limitations of the 980 
nm wavelength compared to the absorption of more 
selective wavelengths, the use of a compact, portable 
30 W Diode Laser appears to be justified as it has 
proved to be effective and safe and well-accepted by 
the patients. 
The use of lasers in general dentistry is now an 
accepted and to some extent, expected treatment 
modality. Laser use can be either an adjunct to other 
procedures or the main form of treatment itself. For 
many procedures, lasers are now becoming the 
treatment of choice by both clinicians and patients, 
and in some cases, the standard of care. Clinicians 
need to learn more about constantly updated tech-
nology and apply newly discovered methods and 
protocols to clinical situations to benefit patients and 
clinicians.  
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